Aug 2026· Journal of Membrane Biology· Vol 259· 0 citations· 65 references
Medicine
TL;DR
Bacterial membrane permeabilization assays confirmed that daptomycin forms stable pores in bacterial membranes large enough to cause leakage of the chromogenic substrate, o-nitrophenyl-β-D-galactopyranoside (ONPG).
Abstract
The global challenge of increasing antibiotic resistance development has necessitated the continued development and investigation of novel and existing antimicrobials. Daptomycin is a cyclic lipopeptide isolated from Streptomyces roseosporus, which has been clinically approved to treat a variety of gram-positive infections. Daptomycin is a membrane-active antimicrobial peptide that requires Ca2+ ions and phosphatidylglycerol lipids to exert its antimicrobial activity. To better understand the mechanism of action at the biophysical level, daptomycin interactions with bilayers and bacterial membranes were evaluated across different solution pH values and by varying cholesterol content in the model membranes. The results demonstrate that pH 5–8 does not affect daptomycin binding to model membranes or its structural rearrangement upon binding to the bilayer. Similarly, including cholesterol up to 30 mol% in the bilayers did not affect daptomycin binding, with an apparent binding affinity of ~ 1 µM under these conditions. Fluorescence quenching experiments showed that Ca2+ binding to daptomycin induced a small but significant shift in the position of Trp in the bilayer, becoming more deeply inserted when calcium was present. Bacterial membrane permeabilization assays confirmed that daptomycin forms stable pores in bacterial membranes large enough to cause leakage of the chromogenic substrate, o-nitrophenyl-β-D-galactopyranoside (ONPG). The data demonstrate a remarkable robustness of daptomycin interactions with lipid bilayers.
Melittin is a well-known antimicrobial peptide whose mechanism of action is still not entirely understood. In this study, we combine complementary experimental techniques with molecular dynamics simulations to determine melittin-membrane interactions at different scales. Using 1,2-dioleoyl-sn-glycero-3-phosphoethanol...
Andrea Chacón Calderón, P. Zelenovskii, M. Soares et al.· Langmuir· 0 citations
Background/Objectives: Antimicrobial peptides are promising agents for combating resistant infections. They exhibit bactericidal activity against a wide range of microbes, primarily by disrupting the permeability of the bacterial membrane and ultimately causing cell death. Effective bacterial killing requires a high nu...
Zahra Vaezi, A. Bortolotti, C. di Stefano et al.· Antibiotics· 0 citations
It is suggested that BCP exhibits moderate growth inhibition associated with membrane related effects and low hemolytic activity, providing insights into the relationship between physicochemical properties, membrane interactions, and biological responses.
Noé Luiz-Santos, J. L. Morales-Landa, J. C. Ruiz-Suárez et al.· Pathogens· 0 citations
Abstract Antibiotic resistance of Gram-positive bacteria poses a major clinical challenge. Daptomycin, a lipopeptide antibiotic, is a treatment option for drug-resistant organisms. However, there have been clinical reports of daptomycin resistance and in vitro reports of daptomycin tolerance that can result in treatmen...
Sudan Maharjan, T. A. Getty, Quiana Dickens et al.· Microbiology· 0 citations
Findings indicate that olikomycin A targets bacterial membranes via calcium‐dependent binding to PG and disrupts membrane integrity through a mechanism distinct from daptomycin.
Luisa Munz, Olga N. Makshakova, S. Marchi et al.· Archiv der Pharmazie· 0 citations
Results suggest that the interaction of Cry4Aa with N-acetylgalactosamine moieties is a vital step in the process of pore formation, and may induce a conformational change in the Cry4Aa molecule that facilitates its insertion into the target membrane.
M. H. Howlader, Taiyo Tsutsui, K. Saito et al.· Applied and Environmental Mi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.